Prostate News Archive
10-Oct-2007
Prostate cancer therapy linked to increased risk of heart disease death (EurekAlert!)
Article: Tsai HK, D?Amico AV, Sadetsky N, Chen M-H, Carroll PR. Androgen Deprivation Therapy for Localized prostate Cancer and the Risk of Cardiovascular Mortality. Hormone Therapy for Prostate Cancer Linked to Heart Risks (HealthDay via Yahoo! News)
TUESDAY, Oct. 9 (HealthDay News) -- prostate cancer patients receiving androgen-deprivation therapy, a common form of hormone treatment proven to slow tumor growth and prolong life, may face a nearly threefold higher risk of dying from heart disease, a new study suggests. Prostate cancer therapy raises heart attack risk (Reuters via Yahoo! News)
The use of androgen deprivation therapy appears to increase the risk of death from cardiovascular disease among men who undergo radical prostatectomy for localized prostate cancer, new research shows. Prostate cancer surgery may be best option (UPI)
Men who had surgery for prostate cancer appear less likely to die of the disease within 10 years than men who had other treatment, a Swiss study found.
Back to Prostate News Archive
